Astrazeneca Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Astrazeneca stocks.

Astrazeneca Stocks Recent News

Date Stock Title
Mar 28 AMGN Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says
Mar 28 AMGN Amgen Options Trading: A Deep Dive into Market Sentiment
Mar 28 AZN Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Mar 28 AMGN How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Mar 28 PTCT PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
Mar 27 AZN Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
Mar 27 AZN Japan approves AstraZeneca-Sanofi drug for prevention of RSV disease in infants
Mar 26 AZN AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
Mar 26 AZN UPDATE 1-China to speed up 'new productive forces', vice president says
Mar 26 AMGN Wall Street Set to Post Fifth Winning Month Amid Volatility
Mar 25 AZN Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know
Mar 25 AZN 31 European Countries That Offer Citizenship by Descent
Mar 25 PTCT A Comprehensive Look at Sarepta's Growth and Innovation
Mar 25 AZN German industry sceptical of China's vow to treat foreign firms equally
Mar 25 AZN Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
Mar 25 AZN ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
Mar 24 AZN Look beyond the Magnificent 7 to the GRANOLAS - Goldman
Mar 24 AMGN 16 Most Undervalued Large Cap Stocks To Buy According To Analysts
Mar 23 RGLS Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
Mar 22 GTHX Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape
Astrazeneca

AstraZeneca plc is a British multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA (location of MedImmune) for work on biopharmaceuticals; and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.The company was founded in 1999 through the merger of the Swedish Astra AB and the English Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014).
AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has secondary listings on the New York Stock Exchange and the OMX exchange.

Browse All Tags